115 related articles for article (PubMed ID: 38809765)
21. Integrated biomarker profiling of the metabolome associated with type 2 diabetes mellitus among Tibetan in China.
Meng J; Huang F; Shi J; Zhang C; Feng L; Wang S; Li H; Guo Y; Hu X; Li X; He W; Cheng J; Wu Y
Diabetol Metab Syndr; 2023 Jul; 15(1):146. PubMed ID: 37393287
[TBL] [Abstract][Full Text] [Related]
22. [Nontargeted lipidomic analysis of sera from sepsis patients based on ultra-high performance liquid chromatography-mass spectrometry/mass spectrometry].
Wang S; Liang J; Shi H; Xia Y; Li J; Wu W; Wang H; Wu W
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Apr; 34(4):346-351. PubMed ID: 35692196
[TBL] [Abstract][Full Text] [Related]
23. High-Performance Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry for Exosome Metabolomics.
Luo X; An M; Cuneo KC; Lubman DM; Li L
Anal Chem; 2018 Jul; 90(14):8314-8319. PubMed ID: 29920066
[TBL] [Abstract][Full Text] [Related]
24. Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics.
Jimenez-Luna C; Martin-Blazquez A; Dieguez-Castillo C; Diaz C; Martin-Ruiz JL; Genilloud O; Vicente F; Del Palacio JP; Prados J; Caba O
Metabolites; 2020 Oct; 10(11):. PubMed ID: 33105675
[TBL] [Abstract][Full Text] [Related]
25. Integrated lipids biomarker of the prediabetes and type 2 diabetes mellitus Chinese patients.
Yang J; Wang M; Yang D; Yan H; Wang Z; Yan D; Guo N
Front Endocrinol (Lausanne); 2022; 13():1065665. PubMed ID: 36743922
[TBL] [Abstract][Full Text] [Related]
26. Integrated biomarker for type 2 diabetes mellitus and impaired fasting glucose based on metabolomics analysis using ultra-high performance liquid chromatography quadrupole-Orbitrap high-resolution accurate mass spectrometry.
Long J; Liu L; Jia Q; Yang Z; Sun Z; Yan C; Yan D
Rapid Commun Mass Spectrom; 2020 Jun; 34(12):e8779. PubMed ID: 32159245
[TBL] [Abstract][Full Text] [Related]
27. Lipidomic Profiles of Plasma Exosomes Identify Candidate Biomarkers for Early Detection of Hepatocellular Carcinoma in Patients with Cirrhosis.
Sanchez JI; Jiao J; Kwan SY; Veillon L; Warmoes MO; Tan L; Odewole M; Rich NE; Wei P; Lorenzi PL; Singal AG; Beretta L
Cancer Prev Res (Phila); 2021 Oct; 14(10):955-962. PubMed ID: 34253566
[TBL] [Abstract][Full Text] [Related]
28. Liver Lipidomics Analysis Revealed the Protective mechanism of Zuogui Jiangtang Qinggan Formula in type 2 diabetes mellitus with non-alcoholic fatty liver disease.
Zhou M; Liu X; Wu Y; Xiang Q; Yu R
J Ethnopharmacol; 2024 Jul; 329():118160. PubMed ID: 38588985
[TBL] [Abstract][Full Text] [Related]
29. Serum Untargeted Metabolomics Reveal Potential Biomarkers of Progression of Diabetic Retinopathy in Asians.
Wang Z; Tang J; Jin E; Zhong Y; Zhang L; Han X; Liu J; Cheng Y; Hou J; Shi X; Qi H; Qian T; Yuan L; Hou X; Yin H; Liang J; Zhao M; Huang L; Qu J
Front Mol Biosci; 2022; 9():871291. PubMed ID: 35755823
[No Abstract] [Full Text] [Related]
30. Untargeted metabolomics reveals altered branch chain amino acids, glucose and fat metabolism contributing to coronary artery disease among Indian diabetic patients.
Adela R; Kasarla SS; Saquib N; Gupta SK; Bajpai S; Kumar Y; Banerjee SK
Mol Omics; 2023 May; 19(4):321-329. PubMed ID: 36752683
[TBL] [Abstract][Full Text] [Related]
31. Distinctive Metabolomics Patterns Associated With Insulin Resistance and Type 2 Diabetes Mellitus.
Gu X; Al Dubayee M; Alshahrani A; Masood A; Benabdelkamel H; Zahra M; Li L; Abdel Rahman AM; Aljada A
Front Mol Biosci; 2020; 7():609806. PubMed ID: 33381523
[TBL] [Abstract][Full Text] [Related]
32. Lipid metabolism analysis for peripheral blood in patients with alcohol
Yan Y; Yu Y; Liu J; Zhao H; Wang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):872-880. PubMed ID: 36039583
[TBL] [Abstract][Full Text] [Related]
33. Metabolic profiles of serum samples from ground glass opacity represent potential diagnostic biomarkers for lung cancer.
Li JZ; Lai YY; Sun JY; Guan LN; Zhang HF; Yang C; Ma YF; Liu T; Zhao W; Yan XL; Li SM
Transl Lung Cancer Res; 2019 Aug; 8(4):489-499. PubMed ID: 31555521
[TBL] [Abstract][Full Text] [Related]
34. Metabolomics Profiling Discriminates Prostate Cancer From Benign Prostatic Hyperplasia Within the Prostate-Specific Antigen Gray Zone.
Xu B; Chen Y; Chen X; Gan L; Zhang Y; Feng J; Yu L
Front Oncol; 2021; 11():730638. PubMed ID: 34722271
[TBL] [Abstract][Full Text] [Related]
35. Lipidomic profiling of exosomes from colorectal cancer cells and patients reveals potential biomarkers.
Elmallah MIY; Ortega-Deballon P; Hermite L; Pais-De-Barros JP; Gobbo J; Garrido C
Mol Oncol; 2022 Jul; 16(14):2710-2718. PubMed ID: 35524452
[TBL] [Abstract][Full Text] [Related]
36. Label-free quantitative proteomics analysis for type 2 diabetes mellitus early diagnostic marker discovery using data-independent acquisition mass spectrometry (DIA-MS).
Nimer RM; Alfaqih MA; Shehabat ER; Mujammami M; Abdel Rahman AM
Sci Rep; 2023 Nov; 13(1):20880. PubMed ID: 38012280
[TBL] [Abstract][Full Text] [Related]
37. Quantitation of serum 25(OH)D2 and 25(OH)D3 concentrations by liquid chromatography tandem mass spectrometry in patients with diabetes mellitus.
Lin YC; Lee HH; Tseng SC; Lin KD; Tseng LP; Lee JF; Lee YH; Chen BH
J Food Drug Anal; 2019 Apr; 27(2):510-517. PubMed ID: 30987722
[TBL] [Abstract][Full Text] [Related]
38. Urinary exosome proteins PAK6 and EGFR as noninvasive diagnostic biomarkers of diabetic nephropathy.
Li T; Liu TC; Liu N; Li MJ; Zhang M
BMC Nephrol; 2023 Oct; 24(1):291. PubMed ID: 37789280
[TBL] [Abstract][Full Text] [Related]
39. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and metabolomics of mild cognitive impairment in type 2 diabetes mellitus.
Luo T; Jiang X; Xu N; Zhao X; Xie X; Xia X; Bian X; Liu H
Front Mol Biosci; 2024; 11():1341290. PubMed ID: 38698772
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
